Table 2 Patient comorbidities: total comorbidity number, medication use, ASA class, and CPS
n (%) | |
|---|---|
Comorbidity | |
Hypertension | 112 (65.9%) |
Respiratory disease (including COPD) | 44 (25.9%) |
Diabetes | 34 (20%) |
Hypothyroid | 33(19.4%) |
Heart failure | 29 (17.1%) |
Osteoarthritis | 26 (15.3%) |
Osteoporosis | 23 (13.5%) |
Smoking history | 19 (11.2%) |
Stroke with residual deficit | 7 (4.1%) |
Myocardial infarction (within last 6 months) | 7 (4.1%) |
Total number of comorbidities | |
None | 15 (8.8%) |
1-2 | 95 (55.9%) |
3-5 | 58 (34.1%) |
> 5 | 2 (1.2%) |
Number of home medications | |
None | 19 (11.2%) |
1-2 | 37 (21.8%) |
3-5 | 81 (47.6%) |
> 5 | 33 (19.4%) |
Home medication use | |
ACE inhibitor | 73 (42.9%) |
Anti-platelet agent | 73 (42.9%) |
Beta-blocker | 66 (38.8%) |
Statin | 62 (36.5%) |
Diuretics | 54 (31.8%) |
Calcium channel blocker | 45 (26.5%) |
Anti-coagulant | 42 (24.7%) |
CPS | |
0-3 | 44 (25.9%) |
4-7 | 80 (47.1%) |
8-10 | 36 (21.2%) |
> 10 | 10 (5.9%) |